Lisa Leese, NP
Women's Health · Oregon, OHNPI 1013253707
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,277 of the $5,395 with a category attached, or 79.3%. Organon accounts for 80.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $4,590 and has fallen 99.1% since, to $43 in 2025. Among women's health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $80.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$4K
- Optumhealth Care Solutions, LLC$230
- AbbVie$166
- Astellas Pharma US Inc$114
- Hologic Sales And Service, LLC$73
- Avion Pharmaceuticals$67
- plus $409 from 12 others
What the payments were for
- Speaking & faculty fees$4,27779%
- Food & beverage$1,01919%
- Education$1002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 14 | $4,335 |
| Optumhealth Care Solutions, LLC | 15 | $230 |
| AbbVie | 10 | $166 |
| Astellas Pharma US Inc | 2 | $114 |
| Hologic Sales And Service, LLC | 2 | $73 |
| Avion Pharmaceuticals | 5 | $67 |
| Aspira Women's Health Inc | 1 | $63 |
| Pfizer | 3 | $57 |
| Mylan Pharmaceuticals Inc. | 3 | $56 |
| Exeltis, USA Inc. | 3 | $49 |
| Abiomed | 1 | $33 |
| Therapeuticsmd, Inc. | 2 | $32 |
| Gynesonics, Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Merck | 1 | $19 |
| Myovant Sciences Inc. | 1 | $17 |
| Scynexis, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$4,180
How this compares
$5,395 in reported general payments places this provider in the 95th percentile of 333 women's health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $1,122 |
| ValacyclovirValacyclovir Hcl | 29 | $703 |
| Fluconazole | 68 | $462 |
| Nystatin | 22 | $459 |
| Metronidazole | 56 | $453 |
| Alendronate Sodium | 60 | $380 |
Paid to pharmacies, not to this prescriber.
Other women's health in Oregon
- Courtney ArnFranklin$195K
- Carrie van ZantBrookville$21K
- Cindy FarinaCleveland$10K
- Kathryn Lowry-CollinsLebanon$9K
- Angalesia RuckerCleveland$9K
- Vivian RuszkiewiczColumbus$6K
- Lauren ZugaWarren$6K
- Carrie BottiggiMayfield Heights$5K
- Tammy LawsonZanesville$4K
- Rebecca EatonMarietta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.